NCT03300232

Brief Summary

Up to one-half of those in treatment for alcohol use disorder (AUD) has a co-occurring anxiety disorder ("comorbidity"), a condition that marks a high degree of treatment resistance, severity and relapse risk in AUD treatment patients. The investigators conceptualize comorbidity as a feed-forward system ("vicious cycle", \[VC\]) of interacting negative affect/stress, drinking motives/behavior, coping skills deficits, environmental circumstances, and neurobiological adaptations. Based on this model, the investigators developed and validated the VC cognitive-behavioral therapy (VC-CBT) to disrupt this system at several key linkage points. In a recently completed randomized controlled trial (RCT), the investigators found that adding the VC-CBT to standard AUD inpatient treatment resulted in better alcohol outcomes 4 months following treatment than did adding an anxiety treatment or standard AUD treatment alone. With a number needed to treat (NNT) index of 8 (relative to standard AUD treatment alone), the VC-CBT could, if broadly disseminated, have a large positive impact on AUD treatment. Unfortunately, several significant barriers related to the resource- and expertise-intensive delivery of the VC-CBT limit its dissemination potential and, hence, the impact of this otherwise effective treatment. Therefore, to maximize the public health and scientific potential of the investigators work, the investigators propose to adapt the therapist-delivered VC-CBT to a computer-delivered format to facilitate reliable and economical dissemination of the VC-CBT while maintaining its established efficacy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 3, 2017

Completed
7 months until next milestone

Study Start

First participant enrolled

April 16, 2018

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 26, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 26, 2021

Completed
Last Updated

September 13, 2022

Status Verified

September 1, 2022

Enrollment Period

3 years

First QC Date

August 3, 2017

Last Update Submit

September 8, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • User ratings

    Likert scale ratings of understanding, engagement, and applicability to current problems

    up to 4 days post-treatment

  • Knowledge Acquisition

    Multiple choice and True/False questions to assess knowledge communicated in program

    up to 4 days post-treatment

  • Skills Acquisition

    Skill demonstration rated by study staff for accuracy

    up to 4 days post-treatment

Study Arms (1)

Computer-based VC-CBT

EXPERIMENTAL

Computer-based VC-CBT: Three, one-hour computerized therapy sessions delivered on an interactive computerized platform with therapy blocks dedicated to each of three primary modules/goals: 1) psycho-education, 2) skills learning, and 3) individualized practice

Behavioral: Computer-based VC-CBT

Interventions

Computer-based VC-CBT: Three, one-hour computerized therapy sessions delivered on an interactive computerized platform with therapy blocks dedicated to each of three primary modules/goals: 1) psycho-education, 2) skills learning, and 3) individualized practice

Computer-based VC-CBT

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnostic and Statistical Manual-IV diagnosis of panic disorder (with or without agoraphobia), generalized anxiety disorder, or social anxiety disorder within the past 30 days
  • Diagnostic and Statistical Manual-IV diagnosis of alcohol dependence within the last 30 days
  • inpatient treatment at Lodging Plus primarily for alcohol (vs. other drug) dependence
  • alcohol use in the 30 days preceding the beginning of their Lodging Plus (LP) treatment
  • willingness and ability to provide informed consent
  • minimum of a sixth grade English reading level (deemed necessary to complete study materials); as determined by their being able to read and understand the consent form
  • familiarity with computer keyboarding as determined by history
  • lives within reasonable driving distance of the Twin Cities and ability to travel to Fairview to allow for in-person follow-up interviews

You may not qualify if:

  • Active psychosis or mania in the three months preceding the study
  • Physical impairment (e.g., blindness, deafness) that interferes with study participation based on self-report or as judged by PI or study physician
  • current significant suicide risk (i.e., intention and plan) as deemed by the PI and study physician to be serious and ongoing
  • primary PTSD as determined by the Structured Clinical Interview for DSM (SCID) interview
  • suspected cognitive impairment that interferes with study participation as informed by the SCID interview or as judged by the PI or study physician

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55408, United States

Location

MeSH Terms

Conditions

Generalized Anxiety DisorderPanic DisorderAlcoholism

Condition Hierarchy (Ancestors)

Anxiety DisordersMental DisordersAlcohol-Related DisordersSubstance-Related DisordersChemically-Induced Disorders

Study Officials

  • Matt Kushner, PhD

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2017

First Posted

October 3, 2017

Study Start

April 16, 2018

Primary Completion

April 26, 2021

Study Completion

July 26, 2021

Last Updated

September 13, 2022

Record last verified: 2022-09

Locations